These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism. Preskorn SH Clin Pharmacokinet; 1997; 32 Suppl 1():1-21. PubMed ID: 9068931 [TBL] [Abstract][Full Text] [Related]
5. Citalopram in the treatment of depression. Parker NG; Brown CS Ann Pharmacother; 2000 Jun; 34(6):761-71. PubMed ID: 10860138 [TBL] [Abstract][Full Text] [Related]
6. Predicting value of tryptophan/large neutral amino acids ratio on selective serotonin reuptake inhibitors. Lucini V; Lucca A; Catalano M; Smeraldi E Adv Exp Med Biol; 1996; 398():559. PubMed ID: 8906324 [No Abstract] [Full Text] [Related]
7. New antidepressants: use in high-risk patients. Hale AS J Clin Psychiatry; 1993 Aug; 54 Suppl():61-70; discussion 71-3. PubMed ID: 8253707 [TBL] [Abstract][Full Text] [Related]
9. Care of depression in the elderly: comparative pharmacokinetics of SSRIs. Baumann P Int Clin Psychopharmacol; 1998 Sep; 13 Suppl 5():S35-43. PubMed ID: 9817619 [TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapeutic approaches to treatment-resistant depression. St John D JAAPA; 2003 Mar; 16(3):32-4, 37-8, 40 passim. PubMed ID: 14968524 [No Abstract] [Full Text] [Related]
11. Could pharmacogenetics play a role as predictor in treatment of depressive disorders? Lee MS World J Biol Psychiatry; 2007; 8(1):2-3. PubMed ID: 17366343 [No Abstract] [Full Text] [Related]
12. Combinatorial Pharmacogenomic Algorithm is Predictive of Citalopram and Escitalopram Metabolism in Patients with Major Depressive Disorder. Shelton RC; Parikh SV; Law RA; Rothschild AJ; Thase ME; Dunlop BW; DeBattista C; Conway CR; Forester BP; Macaluso M; Hain DT; Aguilar AL; Brown K; Lewis DJ; Jablonski MR; Greden JF Psychiatry Res; 2020 Aug; 290():113017. PubMed ID: 32485484 [TBL] [Abstract][Full Text] [Related]
13. Scandinavian experience with citalopram in the elderly. Gottfries CG Int Clin Psychopharmacol; 1996 Mar; 11 Suppl 1():41-4. PubMed ID: 8732444 [TBL] [Abstract][Full Text] [Related]
14. The antidepressant efficacy of citalopram. Montgomery SA; Djärv L Int Clin Psychopharmacol; 1996 Mar; 11 Suppl 1():29-33. PubMed ID: 8732442 [TBL] [Abstract][Full Text] [Related]
16. Update on drugs for emotional pain in elders. Miller CA Geriatr Nurs; 2000; 21(3):164-5. PubMed ID: 10864698 [No Abstract] [Full Text] [Related]
17. Pharmacokinetic-Pharmacodynamic interaction associated with venlafaxine-XR remission in patients with major depressive disorder with history of citalopram / escitalopram treatment failure. Ahmed AT; Biernacka JM; Jenkins G; Rush AJ; Shinozaki G; Veldic M; Kung S; Bobo WV; Hall-Flavin DK; Weinshilboum RM; Wang L; Frye MA J Affect Disord; 2019 Mar; 246():62-68. PubMed ID: 30578947 [TBL] [Abstract][Full Text] [Related]
18. Citalopram approved for treatment of depression. Am J Health Syst Pharm; 1998 Oct; 55(19):1963. PubMed ID: 9784778 [No Abstract] [Full Text] [Related]
19. Citalopram for depression. Med Lett Drugs Ther; 1998 Dec; 40(1041):113-4. PubMed ID: 9854566 [No Abstract] [Full Text] [Related]
20. Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror. Baumann P; Rochat B Int Clin Psychopharmacol; 1995 Mar; 10 Suppl 1():15-21. PubMed ID: 7622807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]